To investigate whether STK10 regulates ICD gene expression or influences ICD-induced immune activation, we treated AML cell lines with SB633825 or knocked out the STK10 gene to assess its impact on cell viability and CALR extracellular exposure. The gene discussed is STK10; the disease is acute myeloid leukemia.